Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應用
4-(Phenylsulfamoyl)benzeneboronic Acid is derived from 4-Bromo-N-phenylbenzenesulfonamide (B687433), which is used in the preparation of 4-Aminopyrazole[3,4-d]pyrimidinylazabicyclo derivatives as BTK inhibitory activity in the prevention or treatment of autoimmune diseases or cancers.
參考文獻
Yoon, Y., et al.: PCT Int. Appl., 189pp., (2018) KR 2016-86257 WO 2017-KR7281
滬ICP備17019645號
400-821-0725
